Menu
GWAS Study

Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.

Höglinger GU, Melhem NM, Dickson DW et al.

21685912 PubMed ID
GWAS Study Type
9012 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

HG
Höglinger GU
MN
Melhem NM
DD
Dickson DW
SP
Sleiman PM
WL
Wang LS
KL
Klei L
RR
Rademakers R
DS
de Silva R
LI
Litvan I
RD
Riley DE
VS
van Swieten JC
HP
Heutink P
WZ
Wszolek ZK
UR
Uitti RJ
VJ
Vandrovcova J
HH
Hurtig HI
GR
Gross RG
MW
Maetzler W
GS
Goldwurm S
TE
Tolosa E
BB
Borroni B
PP
Pastor P
CL
Cantwell LB
HM
Han MR
DA
Dillman A
VD
van der Brug MP
GJ
Gibbs JR
CM
Cookson MR
HD
Hernandez DG
SA
Singleton AB
FM
Farrer MJ
YC
Yu CE
GL
Golbe LI
RT
Revesz T
HJ
Hardy J
LA
Lees AJ
DB
Devlin B
HH
Hakonarson H
MU
Müller U
SG
Schellenberg GD
Chapter II

Abstract

Summary of the research findings

Progressive supranuclear palsy (PSP) is a movement disorder with prominent tau neuropathology. Brain diseases with abnormal tau deposits are called tauopathies, the most common of which is Alzheimer's disease. Environmental causes of tauopathies include repetitive head trauma associated with some sports. To identify common genetic variation contributing to risk for tauopathies, we carried out a genome-wide association study of 1,114 individuals with PSP (cases) and 3,247 controls (stage 1) followed by a second stage in which we genotyped 1,051 cases and 3,560 controls for the stage 1 SNPs that yielded P ≤ 10(-3). We found significant previously unidentified signals (P < 5 × 10(-8)) associated with PSP risk at STX6, EIF2AK3 and MOBP. We confirmed two independent variants in MAPT affecting risk for PSP, one of which influences MAPT brain expression. The genes implicated encode proteins for vesicle-membrane fusion at the Golgi-endosomal interface, for the endoplasmic reticulum unfolded protein response and for a myelin structural component.

1,069 European ancestry cases, 2,958 European ancestry controls, 45 cases, 329 controls

Chapter III

Study Statistics

Key metrics and study information

9012
Total Participants
GWAS
Study Type
Yes
Replicated
1,051 European ancestry cases, 3,560 European ancestry controls
Replication Participants
European, Other
Ancestry
U.S.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.